Carmignac Gestion Acquires New Holdings in Astera Labs, Inc. $ALAB

Carmignac Gestion acquired a new position in Astera Labs, Inc. (NASDAQ:ALAB) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 60,000 shares of the company’s stock, valued at approximately $6,576,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of ALAB. Atreides Management LP raised its position in shares of Astera Labs by 108.9% during the 1st quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after buying an additional 1,754,593 shares in the last quarter. Amundi boosted its holdings in shares of Astera Labs by 1,298.6% in the third quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after acquiring an additional 1,319,643 shares in the last quarter. Artisan Partners Limited Partnership acquired a new position in shares of Astera Labs during the fourth quarter valued at approximately $148,980,000. Goldman Sachs Group Inc. increased its stake in shares of Astera Labs by 189.0% during the fourth quarter. Goldman Sachs Group Inc. now owns 1,312,927 shares of the company’s stock valued at $218,419,000 after acquiring an additional 858,693 shares during the period. Finally, State Street Corp raised its holdings in Astera Labs by 32.5% during the fourth quarter. State Street Corp now owns 3,099,809 shares of the company’s stock worth $515,684,000 after purchasing an additional 760,358 shares in the last quarter. Institutional investors own 60.47% of the company’s stock.

Astera Labs Stock Performance

Shares of NASDAQ:ALAB opened at $311.23 on Monday. The stock has a market capitalization of $53.35 billion, a price-to-earnings ratio of 210.29, a PEG ratio of 3.61 and a beta of 3.84. Astera Labs, Inc. has a 1-year low of $97.89 and a 1-year high of $499.48. The company has a 50 day moving average price of $359.97 and a 200 day moving average price of $230.19.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.07. The firm had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm’s quarterly revenue was up 93.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, sell-side analysts expect that Astera Labs, Inc. will post 1.86 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have weighed in on ALAB. Susquehanna upped their target price on Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a research report on Friday. Jefferies Financial Group reiterated a “buy” rating and set a $270.00 price target on shares of Astera Labs in a research report on Wednesday, May 6th. Weiss Ratings raised Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, May 21st. Stifel Nicolaus raised their target price on Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a research note on Wednesday, June 24th. Finally, Barclays lifted their target price on Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a report on Monday, July 20th. Thirteen investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $284.25.

Insider Buying and Selling at Astera Labs

In related news, Director Manuel Alba sold 8,491 shares of Astera Labs stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $458.38, for a total value of $3,892,104.58. Following the transaction, the director directly owned 286,863 shares in the company, valued at $131,492,261.94. The trade was a 2.87% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bethany Mayer sold 686 shares of the business’s stock in a transaction on Wednesday, June 24th. The stock was sold at an average price of $395.04, for a total value of $270,997.44. Following the sale, the director directly owned 5,550 shares in the company, valued at $2,192,472. This trade represents a 11.00% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 1,676,845 shares of company stock worth $444,928,806. 10.40% of the stock is owned by insiders.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.